Monitoring of omalizumab therapy in children and adolescents
{{output}}
Background: Omalizumab is a successfully implemented supplementary therapy for improving asthma control in children aged 6 years and older with severe persistent allergic asthma. The dosage of omalizumab depends on body weight an... ...
